The jury’s still out on whether or not CBD relieves stress and anxiety.
Academic rigour, journalistic flair
Articles on CBD
Displaying 21 - 40 of 46 articles
It’s important patients taking prescribed medicinal cannabis products are not unduly penalised. But it’s equally important we minimise the chance drivers put themselves or other road users at risk.
CBD retailers were already struggling before the pandemic. The contrast in fortunes with suburban retail activity is stark, and there are good reasons to think the shift could be permanent.
City by city, the data on CBD visitors vary with the severity of COVID-19 outbreaks and restrictions. But none of the CBDs has recovered former activity levels, and some might never fully recover.
Current research suggest it can be both helpful and harmful to memory – here’s why.
Pediatricians say they are getting increasing requests from parents for medical cannabis for kids for a growing list of conditions.
CBD may not be a panacea for your aches and pains – and it certainly isn’t for COVID-19.
Americans love their supplements, but some of the products are contaminated with heavy metals, bacteria and toxic fungi. The FDA has little control because of a law passed in 1994.
Cannabis use is common among trauma survivors, and may improve some of the symptoms of those with PTSD.
Illegal cannabis products still dominate the market. But a fanciful election promise has become mainstream reality.
Pot taxes will change the ability of some to purchase recreational marijuana.
About 470,000 children in the US have epilepsy. Promising advances are being made in the field of epilepsy treatment for children.
There is no evidence yet that cannabidiol (CBD) is effective in treating heroin addiction, despite news headlines claiming this.
A study suggests that CBD could help treat people with opioid addiction. But before you go buy a bottle for any use, it’s important to know that it has been FDA-approved to treat only one disease.
When a city gets to a certain size, it starts to make sense to have multiple centres of activity, and three are planned for Sydney. So what needs to be done to bring the city closer to this goal?
As marijuana and its derivatives are sold legally in more states, pets are getting into pot, accidentally. And some owners are intentionally giving them CBD. A vet explains the dangers.
Cannabidiol, or CBD, is being touted in popular culture as a miracle cure-all. From creams to gummies and more, CBD has exploded onto the health scene. But what does the science actually say?
Research shows that THC and CBD in cannabis have potential to interrupt the vicious cycle of opioid addiction, dependence, withdrawal and relapse.
A drug made from a molecule produced from cannabis gained approval from the FDA on June 25. But the molecule, CBD, is decidedly different from some other ingredients in cannabis: It doesn’t result in a high.
As medicines, not all cannabis products are created equal.
Top contributors
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
Assistant Professor of Psychiatry and Behavioral Neurosciences, Wayne State University
-
Interim Director, UWA Public Policy Institute; Associate Professor & Programme Co-ordinator (Masters of Public Policy), The University of Western Australia
-
Professor of Psychology, Texas State University
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Louise Grimmer is a Friend of The Conversation.
Senior Lecturer in Retail Marketing, University of Tasmania
-
Assistant Professor of Pharmacodynamics, University of Florida
-
Professor of Pharmacy Practice, Drake University
-
Professor of Marketing and Consumer Behaviour, Queensland University of Technology
-
Professor and Chair of Pharmacodynamics, University of Florida
-
Honorary Fellow, Department of Health Sciences, University of York
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Professor and Tyson Endowed Chair in Food Policy Economics, University of Arkansas
-
PhD student in Population and Public Health, University of British Columbia
-
Post-doctoral researcher, UCL
